Want to join the conversation?
$CBG 2Q15 Call: Gross revenue & fee revenue, both rose 12% or 19% in local currency. Normalized EBITDA up 16% or 22% in local currency to $304MM. We achieved a 17.1% normalized EBITDA margin on fee revenue up 60BP from 2Q14. Adjusted earnings per share improved 17% to $0.42 after $0.5 negative impact from adverse foreign currency movement.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?